CONMED stock heads into October 28 results with EPS guidance
Published on 10/04/2026 at 20:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CONMED stock (ISIN US2074101013) was last at USD 46.32 on the NYSE on October 2, 2026, with a daily gain of 0.85 percent. The next company checkpoint is scheduled for October 28, 2026, when CONMED will publish third-quarter results after the market close, as Business Wire reported on October 1, 2026.
October 28 sets the next test
The upcoming report will show whether CONMED can sustain the operating progress behind its revised 2026 outlook. Management will hold a conference call at 4:30 p.m. ET on the same date, according to Business Wire.
The second-quarter figures provide the benchmark. CONMED reported adjusted EPS of USD 1.38, up 20 percent from the year-earlier quarter, while revenue increased 0.3 percent to USD 343.5 million, according to Zacks in its July 30, 2026 report.
Raised EPS guidance meets caution
CONMED raised its full-year 2026 adjusted EPS guidance to USD 4.48-4.60 from USD 4.30-4.45. The company also set third-quarter revenue guidance at USD 334 million-339 million and projected adjusted EPS of USD 0.98-1.03, Zacks reported on July 30, 2026.
The market's earnings lens is more cautious than management's profit outlook. MarketBeat reported on September 4, 2026, that six analysts rated the stock Hold and two rated it Sell, producing a Reduce consensus and an average target of USD 41.40. The average target was below the October 2 price of USD 46.32, making the October results important for testing whether the raised EPS range can support the valuation.
Stock remains below yearly high
CONMED's October 2 price stood USD 7.34 below its 52-week high of USD 53.66 and USD 14.88 above its 52-week low of USD 31.44. The share price therefore sits closer to the top of its annual range than to the bottom, while the next earnings release supplies the clearest scheduled catalyst.
October 2 price and market value
CONMED stock was last at USD 46.32 on the NYSE on October 2, 2026, at 4:00 p.m. ET. Its market capitalization was USD 1.4 billion on that date.
CONMED stock facts
- Company: CONMED Corporation
- ISIN: US2074101013
- WKN: 886793
- Ticker: CNMD
- Trading venue: NYSE
- Price (as of October 2, 2026, 4:00 p.m. ET): USD 46.32
- Market capitalization: USD 1.4 billion (as of October 2, 2026)
- 52-week range: USD 31.44-53.66 (as of October 2, 2026)
- Sector / Industry: Healthcare / Medical Devices
Upcoming dates for CONMED stock
- October 28, 2026: Third-quarter 2026 results after the market close and conference call at 4:30 p.m. ET
